The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

Sage Therapeutics has brought a lawsuit against Biogen shortly after receiving an “unsolicited” offer from its neuroscience ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Biogen’s effort to buy Sage reveals its “desire to expand its pipeline at a discount,” according to analysts from BMO Capital ...